persistent hyperplastic primary vitreous, autosomal recessive

Rare Disease

MONDO:0009097

Also known as:

autosomal recessive persistent hyperplastic primary vitreouspersistent hyperplastic primary vitreous, autosomal recessivePHPVAR

Autosomal recessive form of persistent hyperplastic primary vitreous.

Genes

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Report Generation Failed

We couldn't automatically generate the report. This may be due to temporary service issues.

Companies Active in persistent hyperplastic primary vitreous, autosomal recessive

0 approved

Organizations with approved therapies for this disease

No approved therapies yet

Research is ongoing — 4 companies have orphan drug designations for this disease

Combangio, Inc.

Other

Designated

Glaukos Corporation

Other

Designated

Jade Therapeutics LLC

Other

Designated

Novartis Pharmaceuticals Corporation

Other

Designated

View all companies active in persistent hyperplastic primary vitreous, autosomal recessive

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases